Subscribe to Newsletter

March 2021 Issue of The Medicine Maker

In our March issue, we examine the impact of COVID-19 on pharma, from the use of digital platforms for communication and training to the operational challenges of producing glass vials for vaccines. In Business, we also discuss the long-lasting influence of Brexit on pharma within the UK and beyond its shores. Meanwhile, our cover feature provides a snapshot of the progress being made in neuroscience R&D. Finally, we sit down with Jason Lacombe, CEO of Veratrak, who argues the cases for the uptake of blockchain technologies.

Register to download
Register here to download any issue of The Medicine Maker for FREE.
Login
Forgot your password?
Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Articles featured in this issue

 Discovery & Development COVID-19

Selfishness and Stupidity?

| Stephanie Vine

We have vaccines. Now, pharma’s mission is to address novel variants. And vaccine hesitancy.
Manufacture Small Molecules

Let’s cHAT About Drugs

| Maryam Mahdi

Does pharma really need to pay a high price when it comes to synthetic chemistry?

Discovery & Development Small Molecules

The Powder Problem

| Stephanie Vine

What happens when the same batch of powder gives different results when tested with different laser diffraction testing machines?

Business & Regulation Standards & Regulation

An Inspector Calls?

| Stephanie Vine

How can the FDA tackle the inspection backlog?
Discovery & Development Clinical Trials

A Weighty Loss

| Stephanie Vine

A diabetes drug repurposed for treating obesity shows promise.

Business & Regulation Vaccines

V for Victory?

| Stephanie Vine

Sputnik V (finally and definitely) starts rolling review with the EMA.
Manufacture Bioprocessing - Upstream & Downstream

Medicine Making on Mars

| Stephanie Vine

How will astronauts make medicines in space?
Manufacture Packaging

Who’s the Winner?

| Stephanie Vine

And the winner of The Medicine Maker 2020 Innovation Awards is…

Business & Regulation Business Practice

Many Hands Make Light Work

| Camille Hertzka

Industry collaboration can only result in better treatments for lung cancer.
Manufacture Advanced Medicine

Purifying Gene Therapy

| Akash Bhattacharya

High-level purification maximizes the amount of therapeutic gene payload being delivered with each vector to reduce the risk of immune reaction.

Manufacture Technology and Equipment

Digital Discussion

| Jaleel Shujath

How can artificial intelligence improve access to novel therapeutics?
Discovery & Development Drug Discovery

On the Cusp of Change

| Maryam Mahdi

Is pharma now ushering in a new era of precision in neuroscience R&D?
Discovery & Development Drug Discovery

R&D Without Borders

| Maryam Mahdi

Parkinson’s UK is accelerating drug development through its virtual biotech.
Discovery & Development Drug Discovery

Bridging the Barrier

| Nitin Joshi

Traversing the blood-brain-barrier using nanoparticle technology.
Manufacture Business Practice

No Deal; No More

| James Strachan

After years of speculation, we reveal what Brexit really means for pharma – so far.

Manufacture Bioprocessing - Upstream & Downstream

Biopharma Trends to Watch

| Priyanka Gupta, Amélie Boulais

Find out about the five top trends that will shape biopharma manufacture in 2021.
Manufacture Small Molecules

Two Grand Challenges for Pharma

| Stephanie Vine

A pair of medicines manufacturing initiatives are looking to improve continuous direct compression and clinical trial supply.
Business & Regulation Digital Technologies

Blockchain Brainiac

| Stephanie Vine

We sit down with Jason Lacombe, CEO of Veratrak, to find out more about blockchain for pharma.

Other issues of 2021